Galectin-1 delivery for therapeutic control of intestinal inflammation
US-2025041362-A1 · Feb 6, 2025 · US
Fund Sales patents
Fund Sales holds 5 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 5 |
| Recent patents | 2 |
| First publication | Apr 10, 2018 |
| Latest publication | Feb 6, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
US-11723972-B2 · Aug 15, 2023 · US
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
US-2020093920-A1 · Mar 26, 2020 · US
Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
US-10456465-B2 · Oct 29, 2019 · US
Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
US-9939428-B2 · Apr 10, 2018 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Galectin-1 delivery for therapeutic control of intestinal inflammation
US-2025041362-A1 · Feb 6, 2025 · US
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
US-11723972-B2 · Aug 15, 2023 · US
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
US-2020093920-A1 · Mar 26, 2020 · US
Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
US-10456465-B2 · Oct 29, 2019 · US
Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
US-9939428-B2 · Apr 10, 2018 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 5 |
| Chemistry & Metallurgy | 4 |
| Physics | 1 |
| Cross-Sectional Technologies | 1 |
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Fund Sales have in patentsdb?
- Fund Sales is linked to 5 publications as assignee in our database.
- What technology areas does Fund Sales patent most?
- Top mapped technology areas by patent count: Human Necessities (5); Chemistry & Metallurgy (4); Physics (1).
- Is Fund Sales's patent activity growing?
- In our data, assignee counts were 1 in 2023 and 1 in 2025 (similar year over year).
- What are recent patents assigned to Fund Sales?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.